China Pharma Holdings, Inc. (CPHI) stock
CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
$0.54−0.01 (-1.43%)
Close on Nov 11, 2026Market cap $23.37MP/E –Yield –
China Pharma total assets
Total assets on the balance sheet at the end of each period.
China Pharma's total assets was $44.71M at Jun 30, 2026. For fiscal 2025 it was $31.00M, up 108.2% from the year before. Over ten years it grew -10.7% a year on average. The highest annual figure on record is $163.24M in fiscal 2012.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.00M | +108.2% |
| FY2024 | Dec 31, 2024 | $14.89M | -9.6% |
| FY2023 | Dec 31, 2023 | $16.47M | -7.4% |
| FY2022 | Dec 31, 2022 | $17.78M | -21.5% |
| FY2021 | Dec 31, 2021 | $22.65M | +7.3% |
| FY2020 | Dec 31, 2020 | $21.12M | -5.0% |
| FY2019 | Dec 31, 2019 | $22.24M | -51.0% |
| FY2018 | Dec 31, 2018 | $45.38M | -24.3% |
| FY2017 | Dec 31, 2017 | $59.95M | -23.6% |
| FY2016 | Dec 31, 2016 | $78.52M | -18.6% |
| FY2015 | Dec 31, 2015 | $96.51M | -20.3% |
| FY2014 | Dec 31, 2014 | $121.08M | -23.2% |
| FY2013 | Dec 31, 2013 | $157.61M | -3.4% |
| FY2012 | Dec 31, 2012 | $163.24M | +4.4% |
| FY2011 | Dec 31, 2011 | $156.39M | +18.7% |
| FY2010 | Dec 31, 2010 | $131.75M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $44.71M | +224.8% |
| Q1 FY2026 | Mar 31, 2026 | $45.14M | +217.5% |
| Q4 FY2025 | Dec 31, 2025 | $31.00M | +108.2% |
| Q3 FY2025 | Sep 30, 2025 | $15.80M | +17.4% |
| Q2 FY2025 | Jun 30, 2025 | $13.77M | -3.5% |
| Q1 FY2025 | Mar 31, 2025 | $14.22M | -12.2% |
| Q4 FY2024 | Dec 31, 2024 | $14.89M | -9.6% |
| Q3 FY2024 | Sep 30, 2024 | $13.47M | -12.3% |
| Q2 FY2024 | Jun 30, 2024 | $14.26M | -9.2% |
| Q1 FY2024 | Mar 31, 2024 | $16.19M | -6.7% |
| Q4 FY2023 | Dec 31, 2023 | $16.47M | -7.4% |
| Q3 FY2023 | Sep 30, 2023 | $15.35M | -5.3% |
| Q2 FY2023 | Jun 30, 2023 | $15.70M | -12.4% |
| Q1 FY2023 | Mar 31, 2023 | $17.36M | -17.5% |
| Q4 FY2022 | Dec 31, 2022 | $17.78M | -21.5% |
| Q3 FY2022 | Sep 30, 2022 | $16.20M | -10.9% |
| Q2 FY2022 | Jun 30, 2022 | $17.92M | -10.2% |
| Q1 FY2022 | Mar 31, 2022 | $21.04M | +6.0% |
| Q4 FY2021 | Dec 31, 2021 | $22.65M | +7.3% |
| Q3 FY2021 | Sep 30, 2021 | $18.18M | -13.9% |
| Q2 FY2021 | Jun 30, 2021 | $19.94M | -13.9% |
| Q1 FY2021 | Mar 31, 2021 | $19.85M | -11.5% |
| Q4 FY2020 | Dec 31, 2020 | $21.12M | -5.0% |
| Q3 FY2020 | Sep 30, 2020 | $21.12M | -47.1% |
| Q2 FY2020 | Jun 30, 2020 | $23.17M | -46.2% |
| Q1 FY2020 | Mar 31, 2020 | $22.44M | -50.4% |
| Q4 FY2019 | Dec 31, 2019 | $22.24M | -51.0% |
| Q3 FY2019 | Sep 30, 2019 | $39.90M | -24.0% |
| Q2 FY2019 | Jun 30, 2019 | $43.03M | -26.2% |
| Q1 FY2019 | Mar 31, 2019 | $45.24M | -27.2% |
| Q4 FY2018 | Dec 31, 2018 | $45.38M | -24.3% |
| Q3 FY2018 | Sep 30, 2018 | $52.53M | -29.9% |
| Q2 FY2018 | Jun 30, 2018 | $58.31M | -24.4% |
| Q1 FY2018 | Mar 31, 2018 | $62.13M | -20.5% |
| Q4 FY2017 | Dec 31, 2017 | $59.95M | -23.6% |
| Q3 FY2017 | Sep 30, 2017 | $74.99M | -14.2% |
| Q2 FY2017 | Jun 30, 2017 | $77.12M | – |
| Q1 FY2017 | Mar 31, 2017 | $78.14M | – |
| Q4 FY2016 | Dec 31, 2016 | $78.52M | – |
| Q3 FY2016 | Sep 30, 2016 | $87.41M | – |
See a number that looks wrong?